Humanwell Healthcare Co.,Ltd. cancelled the acquisition of 70 percent stake in Chengdu Wanlongyikang Pharmaceutical Co., Ltd. from Tibet Xinyikang Pharmaceutical Holdings Co., Ltd. - Marketscreener.com
| 600079 Stock | 24.02 0.13 0.54% |
About 55% of Humanwell Healthcare's investor base is interested to short. The analysis of overall sentiment of trading Humanwell Healthcare Group stock suggests that many investors are impartial at this time. The current market sentiment, together with Humanwell Healthcare's historical and current headlines, can help investors time the market. In addition, many technical investors use Humanwell Healthcare stock news signals to limit their universe of possible portfolio assets.
Humanwell |
Humanwell Healthcare Co.,Ltd. cancelled the acquisition of 70 percent stake in Chengdu Wanlongyikang Pharmaceutical Co., Ltd. from Tibet Xinyikang Pharmaceutical Holdings Co., Ltd. Marketscreener.com
Read at news.google.com
 |
Humanwell Healthcare Fundamental Analysis
We analyze Humanwell Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humanwell Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humanwell Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Humanwell Healthcare is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Humanwell Healthcare Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Humanwell Healthcare stock to make a market-neutral strategy. Peer analysis of Humanwell Healthcare could also be used in its relative valuation, which is a method of valuing Humanwell Healthcare by comparing valuation metrics with similar companies.
Peers
Humanwell Healthcare Related Equities
| 300750 | Contemporary Amperex | 2.47 | ||||
| 600519 | Kweichow Moutai | 2.02 | ||||
| 603444 | G Bits | 1.20 | ||||
| 002371 | NAURA Technology | 1.18 | ||||
| 688169 | Beijing Roborock | 0.61 | ||||
| 688235 | BeiGene | 0.51 | ||||
| 600941 | China Mobile | 0.78 | ||||
| 000661 | Changchun High | 0.95 | ||||
| 688399 | Jiangsu Bioperfectus | 4.23 |
Complementary Tools for Humanwell Stock analysis
When running Humanwell Healthcare's price analysis, check to measure Humanwell Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humanwell Healthcare is operating at the current time. Most of Humanwell Healthcare's value examination focuses on studying past and present price action to predict the probability of Humanwell Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humanwell Healthcare's price. Additionally, you may evaluate how the addition of Humanwell Healthcare to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |